CSL BEHRING GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 56199
 
  
 
C07K PEPTIDES 32104
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 16151
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 3237
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 2138
 
  
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 262
 
  
 
B67D DISPENSING, DELIVERING, OR TRANSFERRING LIQUIDS, NOT OTHERWISE PROVIDED FOR 240

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0036,394 PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITORFeb 19, 16Feb 08, 18[A61K]
2017/0209,546 IMPROVED FACTOR VIII PREPARATIONS SUITABLE FOR THERAPEUTIC USE AND PROCESSES TO OBTAIN THESEJul 24, 15Jul 27, 17[A61K, G01N]
2017/0143,805 METHOD OF PURIFYING THERAPEUTIC PROTEINSFeb 03, 17May 25, 17[A61K]
2017/0137,536 INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USESNov 04, 16May 18, 17[C07K]
2017/0121,423 INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USESNov 04, 16May 04, 17[C07K]
2017/0114,119 THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDERJun 18, 15Apr 27, 17[A61K, C07K]
2016/0166,660 COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITORJun 27, 14Jun 16, 16[A61K]
2015/0150,911 METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINSMay 14, 12Jun 04, 15[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9856325 Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodiesNov 04, 16Jan 02, 18[C07H, A61K, C07K]
9856326 Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodiesNov 04, 16Jan 02, 18[A61K, C07K]
9707269 Sugar compositions for treating hemophilia A and/or von Willebrand diseaseMar 15, 13Jul 18, 17[A61K]
9624307 Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organsMar 09, 12Apr 18, 17[A61K, G01N, C07K]
9598461 Method of purifying therapeutic proteinsNov 06, 14Mar 21, 17[A61K, C07K]
9518127 Inhibitory anti-factor XII/XIIA monoclonal antibodies and their usesJul 20, 12Dec 13, 16[A61K, C07K]
9511123 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIIIOct 18, 12Dec 06, 16[A61K]
9474851 Holder for an injection syringeJun 15, 11Oct 25, 16[A61M]
9458223 Von willebrand factor variants having improved factor VIII binding affinityFeb 14, 13Oct 04, 16[A61K, C07K]
9452203 Use of C1-inhibitor for the treatment of secondary edema of the central nervous systemDec 21, 12Sep 27, 16[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0356,346 MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFEAbandonedMay 15, 14Dec 04, 14[C12N, C07K]
2014/0273,096 MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFEAbandonedApr 09, 14Sep 18, 14[C07K]
2014/0248,686 THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERYAbandonedMar 27, 14Sep 04, 14[C12N]
2014/0154,233 METHOD OF PURIFYING THERAPEUTIC PROTEINSAbandonedMar 14, 13Jun 05, 14[A61K, C07K]
2013/0337,532 THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERYAbandonedJun 19, 13Dec 19, 13[C12N]
2013/0177,547 ANCESTRAL SERINE PROTEASE COAGULATION CASCADE EXERTS A NOVEL FUNCTION IN EARLY IMMUNE DEFENSEAbandonedJul 20, 11Jul 11, 13[A61K]
2012/0148,688 PREVENTION OF THROMBUS FORMATION AND/OR STABILIZATIONAbandonedDec 29, 11Jun 14, 12[A61K, A61P]
2012/0039,901 METHOD FOR THE PREVENTION AND TREATMENT OF CANCER BY INHIBITION OF GPVIAbandonedSep 28, 11Feb 16, 12[A61K, G01N, A61P]
2011/0305,709 CALCIUM SENSOR STIM1 AND THE PLATELET SOC CHANNEL ORAI1 (CRACM1) ARE ESSENTIAL FOR PATHOLOGICAL THROMBUS FORMATIONAbandonedMar 20, 09Dec 15, 11[A61K, C12Q, A61P]
2011/0189,182 PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITYAbandonedMar 29, 11Aug 04, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2011/0124,565 Modified Coagulation Factor VIII With Enhanced Stability and Its DerivativesAbandonedApr 10, 06May 26, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2011/0044,993 METHOD FOR THE PREVENTION AND TREATMENT OF CANCER BY INHIBITION OF GPVIAbandonedApr 20, 09Feb 24, 11[A61K, G01N, A61P]
2010/0273,206 DIAGNOSTIC IN VITRO METHOD FOR ASSESSING VON WILLEBRAND DISEASE AND INCREASED BLEEDING RISK ASSOCIATED WITH VON WILLEBRAND DISEASE AND ACQUIRED OR CONGENITAL DISORDERS OF PLATELET FUNCTIONAbandonedDec 18, 08Oct 28, 10[C12Q]
2010/0222,554 Method of Increasing the In Vivo Recovery of Therapeutic PolypeptidesAbandonedApr 02, 07Sep 02, 10[C07K]
2010/0168,000 Octanoate-Reduced Human AlbuminAbandonedDec 13, 06Jul 01, 10[A61K, A61P, C07K]
2009/0118,163 Factor H for the Treatment of Chronic Nephropathies and Production thereofAbandonedJun 13, 06May 07, 09[A61K, A61P, C07K]
2009/0042,787 Proteolytically cleavable fusion proteins with high molar specific activityAbandonedJun 14, 07Feb 12, 09[A61K, C07H, C12P, C12N, A61P, C07K]
2008/0317,735 Pharmaceutical preparation with RNA as hemostasis cofactorAbandonedAug 07, 08Dec 25, 08[A61K, A61P]
2007/0167,361 Use of factor XIII for stimulating the perfusion of ischemic tissueAbandonedFeb 15, 05Jul 19, 07[A61K]
2007/0036,784 Medicament for the protection against thrombotic diseasesAbandonedJul 27, 06Feb 15, 07[A61K, G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.